(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

The Week On The Horizon: Nu Holdings, Costamare, Monday.com, SNDL

May 13th, 2023

On Monday, May 15, several notable companies are expected to report their financial results.  Nu Holdings Ltd. (NYSE: NU) will release its Q1'23 financial results after the market closes. Analysts are predicting a consensus EPS of $0.02 on re. Read more

Major Announcements in the Industry: Momentus Secures SpaceX Deal, Clearmind Medicine Receives Trial Approval, and SCYNEXIS Enters Exclusive License Agreement with GSK

May 12th, 2023

In recent updates, several companies have made significant announcements in their respective fields. Here's a breakdown of the latest developments: Momentus Inc. (Nasdaq: MNTS) has entered into a contract with SpaceX, securing a port reservation o. Read more

Price Targets and Ratings Shift: Updates on Polestar, Barclays, Fiverr, and Allakos

May 12th, 2023

In recent market updates, several notable companies have seen changes in their price targets and stock performance. Here's a breakdown of the latest developments: Polestar Automotive Holding UK PLC (Nasdaq: PSNY) had its price target adjusted by C. Read more

Getaround's Acquisition and ARS Pharmaceuticals' Positive FDA Committee Vote Drive Surge in Pre-Market Trading

May 12th, 2023

In exciting news, Getaround, Inc. (NYSE: GETR) has announced its acquisition of the majority of assets from HyreCar, a leading gig carsharing marketplace. The purchase price for this transaction amounts to an impressive $9.45 million. By integrating . Read more

Ouster's Strong Q1 Revenue Performance Ignites Market Excitement, While BIOLASE and IonQ Face Challenges

May 11th, 2023

Ouster, Inc. (NYSE: OUST), a leading provider of advanced sensor technology, unveiled its financial results for the first quarter of 2023. Angus Pacala, the CEO of Ouster, expressed his satisfaction with the company's performance, stating, "Ouster ha. Read more

Market Volatility Unleashed: Earnings Propel Blue Bird and SurgePays, While AVITA Medical Faces Challenges

May 11th, 2023

In the realm of financial markets, several companies released their quarterly earnings reports, revealing significant developments that prompted notable changes in their stock prices during after-hours trading. Blue Bird Corporation (Nasdaq: BLBD). Read more

Maxeon's Shining Performance, Digimarc's Lucrative Contract, and Magnite's Unexpected Win: Q1 Earnings Recap

May 11th, 2023

Maxeon Solar Technologies, Ltd. (Nasdaq: MAXN) surprised the market with its impressive first-quarter earnings. The company reported earnings per share (EPS) of $0.46, defying the consensus estimate of a loss of $0.47 per share. This outstanding perf. Read more

Sunshine Biopharma Reports Exponential Q1 Revenue Growth; Jaguar Health's Canalevia-CA1 Now Available on Chewy; Albemarle Upgraded: Market Highlights

May 11th, 2023

Sunshine Biopharma, Inc. (Nasdaq: SBFM) has released its 2023 First Quarter Results, showcasing impressive growth. The company reported gross revenues of $4,894,053 as of March 31, 2023, marking an exceptional increase of more than 2,100% compared to. Read more

Barclays Downgrades Northrop Grumman, ROTH MKM Upgrades Roblox: Pre-Market Insights on NOC, RBLX, LTHM, and SPCE

May 11th, 2023

Barclays has downgraded Northrop Grumman Corporation (NYSE: NOC) from Overweight to Equal Weight and lowered the price target from $580 to $450. In pre-market trading, the stock is currently trading at $439.49, down $3.54 or 0.80%. On the other ha. Read more

Earnings Surprise: Veru Struggles, YETI and NICE Beat Expectations, JD.com Surges

May 11th, 2023

Today's pre-market trading session has seen a mixed bag of results from several companies reporting their Q1 or Q2 earnings. Veru Inc. (Nasdaq: VERU) has reported a Q2 loss of $0.48 per share, which is worse than the consensus estimate of $0.33 loss . Read more